Ascentage Pharma Group International (AAPG) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ascentage Pharma Group In...

    NASDAQ: AAPG · Real-Time Price · USD
    39.38
    -0.40 (-1.01%)
    At close: Oct 03, 2025, 3:59 PM
    39.38
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Ascentage Pharma International Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 980.65M 221.98M 209.71M 4.33M
    Cost of Revenue
    		 29.09M 30.54M 22M 3.33M
    Gross Profit
    		 951.57M 191.44M 187.71M 24.58M
    Operating Income
    		 -369.73M -872.64M -849.81M -869.84M
    Interest Income
    		 37.84M 32.41M 9.73M 7.11M
    Pretax Income
    		 -395.25M -932.86M -887.17M -832.25M
    Net Income
    		 -405.43M -925.64M -882.92M -782.42M
    Selling & General & Admin
    		 383.12M 376.46M 328.02M 191.26M
    Research & Development
    		 947.25M 706.97M 743.1M 766.49M
    Other Expenses
    		 -9.07M -19.36M -33.6M -63.34M
    Operating Expenses
    		 1.32B 1.06B 1.04B 894.42M
    Interest Expense
    		 64.45M 96.06M 52.78M 16.73M
    Selling & Marketing Expenses
    		 196M 195.39M 157.42M 47.75M
    Cost & Expenses
    		 1.35B 1.09B 1.06B 897.75M
    Income Tax Expense
    		 10.43M -7.15M -4.25M -49.83M
    Shares Outstanding (Basic)
    		 302.06M 70.57M 65.92M 63.65M
    Shares Outstanding (Diluted)
    		 302.06M 70.57M 65.92M 63.65M
    EPS (Basic)
    		 -0.75 -13.12 -13.4 -12.28
    EPS (Diluted)
    		 -0.75 -13.12 -13.4 -12.28
    EBITDA
    		 -237.63M -743.61M -771.47M -787.19M
    EBIT
    		 -330.8M -836.8M -834.39M -815.52M
    Depreciation & Amortization
    		 93.17M 93.19M 9.13M 4.39M

    Add to Watchlist